Skip to main content
. Author manuscript; available in PMC: 2021 Dec 28.
Published in final edited form as: Clin Immunol. 2020 Apr 21;215:108440. doi: 10.1016/j.clim.2020.108440

Table 1.

Patients’ characteristics.

HC PHIV R NR P value
n 8 19 9 10
Gender (F) 4 8 4 4 n.s.
Age (years) (mean, SEM) 18.8 (4.4) 14.4 (1.3) 14.9 (1.3) 13.7 (2.5) n.s.
HIV RNA < 50cp/mL (n) 19 9 10
H1N1 HAI fold change T1/T0 (mean, SEM) 20 (1.15) 19 (7.2) 1 (0) HC vs NR = **
R vs NR = **
H1N1 HAI titer ≥ 1:40 at T0 6/8 17/19 8/9 9/10 n.s.
Lymphocytes/μL (mean, SEM) 2890 (194.72) 2595 (222.6) 2720 (173.6) 3016 (359.1) n.s.
CD4+ (mean, SEM) 39.4 (3.9) 44.5 (5.8) 41.5 (8.7) 50.3 (7.5) n.s.
CD19+ (mean, SEM) 7.9 (2.1) 8.9 (1.6) 7.9 (8.8) 10.0 (2.9) n.s.
CD19 + CD27 + IgD− (mean, SEM) 13.3 (3.1) 14.3 (2.1) 12.7 (2.8) 16.2 (3.3) n.s.

n, number of patients; HC, Healthy Controls; R, Responders; NR, Non Responders; F, Female; RM, Resting Memory; AM, Activated Memory; SEM, Standard Error of the Mean; n.s., p value>.5; ** = 0.0078).